In combination with radiation treatment, researchers are testing a new drug that causes DNA damage to make that treatment more effective.
Can higher glucose levels make chemotherapy more effective? Dr. Jordan Winter and colleagues are studying the relationship.
Break Through Cancer was founded to promote collaboration between major research institutions, in order to develop cures for the deadliest cancers.
Will a chemotherapy combination be effective against PNET after high-grade tumors are surgically removed? A clinical trial takes a closer look.
Researchers are testing a type of targeted therapy called a PARP inhibitor for cancers carrying the PALB2 mutation.
Researchers are comparing chemotherapy regimens for effectiveness before surgery, and whether switching treatments makes a difference.
The 2023 AACR meeting focused on the latest research into KRAS, other immunotherapy approaches, and honored Dr. Elizabeth Jaffee.
Researchers are comparing effectiveness of chemotherapy before surgery (neoadjuvant) with chemotherapy after surgery (adjuvant).